BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8610280)

  • 21. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between disseminated intravascular coagulation and levels of plasma thrombinogen segment 1+2, D-dimer, and thrombomodulin in patients with multiple injuries.
    Zhu YJ; Huang XK
    Chin J Traumatol; 2009 Aug; 12(4):203-9. PubMed ID: 19635212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Morimoto Y; Ishitani T; Kemmotsu O
    Thromb Res; 2003 Jan; 109(2-3):119-24. PubMed ID: 12706640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated intravascular coagulation in trauma patients.
    Gando S
    Semin Thromb Hemost; 2001 Dec; 27(6):585-92. PubMed ID: 11740682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
    Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
    Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia.
    Ogura H; Gando S; Iba T; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Murata A; Ikeda T; Ishikura H; Ueyama M; Kushimoto S; Saitoh D; Endo S; Shimazaki S;
    Shock; 2007 Oct; 28(4):411-7. PubMed ID: 17577138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome.
    Kobayashi S; Gando S; Morimoto Y; Nanzaki S; Kemmotsu O
    Surg Today; 2001; 31(10):853-9. PubMed ID: 11759877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment.
    Hayakawa M; Yamamoto H; Honma T; Mukai N; Higashiyama A; Sugano M; Kubota N; Uegaki S; Sawamura A; Gando S
    Shock; 2012 Jun; 37(6):569-73. PubMed ID: 22552020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.
    Takeuchi M; Tanoshima R; Miyagawa N; Sarashina T; Kato H; Kajiwara R; Ito S; Goto H
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27734584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection.
    Madoiwa S; Honda G; Kawano N; Uchiyama T; Kawasugi K; Takezako N; Suzuki K; Seki Y; Ikezoe T; Okamoto K; Wada H
    Int J Lab Hematol; 2021 Dec; 43(6):1566-1574. PubMed ID: 34228395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
    Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
    Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
    World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis.
    Endo S; Inada K; Nakae H; Takakuwa T; Kasai T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):277-88. PubMed ID: 8747795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study.
    Takahashi G; Shibata S; Ishikura H; Miura M; Fukui Y; Inoue Y; Endo S
    Eur J Anaesthesiol; 2015 Mar; 32(3):199-206. PubMed ID: 25387303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass.
    el-Barbary M; Khabar KS
    Crit Care Med; 2002 Aug; 30(8):1712-6. PubMed ID: 12163781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
    J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.